NLS Pharmaceutics Ltd (NLSP)
0.1418
0.00 (0.00%)
USD |
NASDAQ |
Apr 30, 15:39
NLS Pharmaceutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
AC Immune SA | 0.00 |
CRISPR Therapeutics AG | 0.00 |
Addex Therapeutics Ltd | 0.00 |
Molecular Partners AG | 0.00 |
MoonLake Immunotherapeutics | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 2.270M |
Total Liabilities (Quarterly) | 6.557M |
Shareholders Equity (Quarterly) | -4.287M |